Workflow
正帆科技(688596) - 2024 Q1 - 季度财报
688596GenTech(688596)2024-04-29 12:41

Financial Performance - In Q1 2024, the total revenue reached CNY 645,883,815.86, an increase from CNY 528,527,703.63 in Q1 2023, representing a growth of approximately 22.2%[3] - The company reported a basic and diluted earnings per share of CNY 0.09, up from CNY 0.04 in Q1 2023, reflecting a 125% increase[3] - The company's operating revenue for Q1 2024 reached ¥588.73 million, representing a 43.31% increase year-over-year[12] - Net profit attributable to shareholders was ¥24.90 million, a significant increase of 123.36% compared to the same period last year[12] - The net profit excluding non-recurring gains and losses was ¥16.34 million, reflecting a 122.29% increase year-over-year[12] - Net profit for Q1 2024 was ¥35.01 million, compared to ¥14.96 million in Q1 2023, representing a 134.0% increase[42] - Profit before tax for Q1 2024 was ¥32.08 million, up from ¥14.10 million in Q1 2023, marking a 127.6% increase[42] - The net profit attributable to shareholders of the parent company was ¥24.90 million, compared to ¥11.15 million in the same quarter last year, reflecting a 123.5% growth[42] Cash Flow and Financial Position - The net cash flow from operating activities was CNY -210,745,939.20, compared to CNY -129,857,764.49 in the same period last year, indicating a decline in cash flow[4] - The net cash increase for the period was CNY 18,612,987.62, contrasting with a decrease of CNY -296,367,704.79 in the same quarter last year[6] - The cash flow from financing activities generated a net amount of CNY 333,997,196.43, compared to a net outflow of CNY -84,268,269.57 in Q1 2023[6] - The company reported a net cash flow from operating activities of -¥210.75 million, indicating a significant increase in contract backlog and inventory payments compared to the previous year[13] Research and Development - Research and development expenses totaled CNY 53,405,265.79, accounting for 9.07% of operating revenue, which is an increase of 0.73 percentage points year-over-year[9] - R&D investment totaled ¥55.95 million, primarily due to increased material consumption and employee compensation in technology expansion and new product development[13] - Research and development expenses increased to ¥53.41 million, a 56.2% rise from ¥34.25 million in the previous year[41] Assets and Liabilities - Total assets increased to CNY 8,664,847,478.06, up 7.43% from CNY 8,065,228,289.12 at the end of the previous year[9] - Total current assets increased to ¥6,892,157,130.40 from ¥6,424,881,965.46, representing a growth of approximately 7.3% year-over-year[33] - Total liabilities increased to ¥5,519,210,493.61 from ¥5,010,697,923.35, reflecting a growth of approximately 10.1%[39] - Total equity attributable to shareholders reached ¥3,067,094,188.67, up from ¥3,001,886,794.49, marking an increase of about 2.2%[36] - The company’s total equity increased to ¥3,145,636,984.45 from ¥3,054,530,365.77, representing a growth of approximately 3.0%[36] Inventory and Receivables - Inventory rose to ¥3,875,479,718.89, up from ¥3,376,622,490.98, indicating an increase of about 14.8%[38] - Accounts receivable decreased to ¥1,423,728,622.38 from ¥1,536,343,053.84, showing a decline of about 7.4%[33] Contracts and Backlog - The company signed new contracts worth ¥1.8 billion in Q1 2024, a 22% increase year-over-year, with 46% coming from the semiconductor industry[24] - The total contract backlog reached ¥7.5 billion, a 68% increase year-over-year, with 53% from the semiconductor sector[24] Other Financial Metrics - Other income for Q1 2024 was reported at ¥22.18 million, significantly higher than ¥3.55 million in Q1 2023[41] - The company recorded a foreign exchange loss of ¥3.63 million in Q1 2024, compared to a gain of ¥75,123.29 in the previous year[42] - Tax expenses for Q1 2024 were ¥2.93 million, compared to ¥856,376.33 in Q1 2023, indicating a substantial increase in tax obligations[42] - The company experienced a credit impairment loss of ¥4.50 million in Q1 2024, compared to a loss of ¥1.21 million in the same period last year[42] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 7,907[30] - The company’s cash and cash equivalents amounted to ¥621,027,615.24, compared to ¥605,556,875.87, reflecting a slight increase of about 2.4%[33] Financing Activities - The company has received approval from the Shanghai Stock Exchange for its convertible bond issuance application, which is currently under review[24] - Short-term borrowings rose significantly to ¥434,526,003.77 from ¥255,522,991.36, an increase of approximately 69.9%[39]